Skip to main content

Table 1 Clinical features of patients with Parkinson’s disease (n = 106)

From: Analysis of non-invasive gait recording under free-living conditions in patients with Parkinson’s disease: relationship with global cognitive function and motor abnormalities

Age (years)68.0 ± 6.7
Male/female (n)62/44
Disease duration (years)2.3 ± 2.6
LEDD100.8 ± 155.1
MMSE27.8 ± 2.0
Modified HY stage2.3 ± 0.6
UPDRS Part III score17.3 ± 9.0
Gait cycle duration (sec)1.18 ± 0.12
Gait acceleration amplitude (m/sec2)1.83 ± 0.36
  1. Data are mean ± standard deviation
  2. LEDD levodopa equivalent daily dose; MMSE Mini-Mental State Examination; Modified HY stage modified Hoehn and Yahr stage; UPDRS Part III score Unified Parkinson’s disease rating scale part III score